Clinical in vitro endothelialization of femoropopliteal bypass grafts: An actuarial follow-up over three years
Peter Zilla(University of Cape Town), T Fischlein(Barmherzige Schwestern vom heiligen Kreuz), Herbert Lugmaier(Barmherzige Schwestern vom heiligen Kreuz), Rudolf Puschmann(Barmherzige Schwestern vom heiligen Kreuz), Thomas Eberl(Barmherzige Schwestern vom heiligen Kreuz), Péter Schmidt(Barmherzige Schwestern vom heiligen Kreuz), Irene Noszian(Barmherzige Schwestern vom heiligen Kreuz), Robert Dudczak(Barmherzige Schwestern vom heiligen Kreuz), Johann Meinhart(Barmherzige Schwestern vom heiligen Kreuz), Erich Minar(Medical University of Vienna), Manfred Deutsch(Barmherzige Schwestern vom heiligen Kreuz)
Cited by 208
Related Papers
Balloon Angioplasty versus Implantation of Nitinol Stents in the Superficial Femoral Artery
|New England Journal of Medicine|2006|1.2k
High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism
|New England Journal of Medicine|2000|765
Nitinol Stent Implantation Versus Percutaneous Transluminal Angioplasty in Superficial Femoral Artery Lesions up to 10 cm in Length
|Circulation|2007|515
Sustained Benefit at 2 Years of Primary Femoropopliteal Stenting Compared With Balloon Angioplasty With Optional Stenting
|Circulation|2007|500
The Risk of Recurrent Venous Thromboembolism in Men and Women
|New England Journal of Medicine|2004|478